openPR Logo
Press release

Global Central Nervous System (CNS) Therapeutics Market Size To Hit US$ 214.6 Billion by 2028 | IMARC Group

03-31-2023 10:47 AM CET | Health & Medicine

Press release from: IMARC Group

Global Central Nervous System (CNS) Therapeutics Market Size

According to IMARC Group's latest report, titled "๐‚๐ž๐ง๐ญ๐ซ๐š๐ฅ ๐๐ž๐ซ๐ฏ๐จ๐ฎ๐ฌ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ (๐‚๐๐’) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ง๐—ฟ๐—ฒ๐—ป๐—ฑ๐˜€, ๐—ฆ๐—ต๐—ฎ๐—ฟ๐—ฒ, ๐—ฆ๐—ถ๐˜‡๐—ฒ, ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต, ๐—ข๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜๐˜‚๐—ป๐—ถ๐˜๐˜† ๐—ฎ๐—ป๐—ฑ ๐—™๐—ผ๐—ฟ๐—ฒ๐—ฐ๐—ฎ๐˜€๐˜ 2023-2028", the central nervous system (CNS) therapeutics market reached US$ 131.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 214.6 Billion by 2028, exhibiting a CAGR of 6.8% during 2023-2028.

The central nervous system (CNS) represents a vital part of the nervous system that consists of the brain and the spinal cord. It incorporates the received information, thereafter, controlling and coordinating the activities of all aspects of the body. However, various CNS disorders, such as neurodegenerative diseases, autoimmune and inflammatory illnesses, genetic disorders, cancers, and others, affect the structure and function of the brain or spinal cord. Thus, CNS therapeutics are used to treat these disorders. These medications include sedatives, tranquilizers, and hypnotics that can slow brain activity, making them useful for treating panic, acute stress reactions, anxiety, and sleep disorders in individuals.

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐…๐—ฟ๐—ฒ๐—ฒ ๐’๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐๐—ฟ๐—ผ๐—ฐ๐—ต๐˜‚๐—ฟ๐—ฒ: https://www.imarcgroup.com/central-nervous-system-therapeutics-market/requestsample

๐†๐ฅ๐จ๐›๐š๐ฅ ๐‚๐ž๐ง๐ญ๐ซ๐š๐ฅ ๐๐ž๐ซ๐ฏ๐จ๐ฎ๐ฌ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ (๐‚๐๐’) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ

The rising approval of generic products, owing to patent expiration of essential medicines, such as Copaxone and Invega, has led to an expansion in treatment rate, especially in low- and middle-income countries, which is among the primary factors driving the central nervous system (CNS) therapeutics market. Besides this, the launch of several policies by the government bodies to boost the number of clinical trials and the introduction of innovative medications with improved efficacy, dosage, formulation, and aftereffects are further augmenting the market growth.

Moreover, the growing popularity of transdermal patches for central nervous system disorders that provide a precise amount of medicine and relief is also catalyzing the global market. Apart from this, the increasing advancements in the drug-delivery systems that have an edge over conventional methods, on account of the reduced adverse effects, are acting as significant growth-inducing factors. Furthermore, the elevating focus of the leading pharmaceutical players toward new therapies to prevent or enhance the symptoms of neurological disorders is expected to bolster the central nervous system (CNS) therapeutics market in the coming years.

๐—–๐—ต๐—ฒ๐—ฐ๐—ธ๐—ผ๐˜‚๐˜ ๐—ก๐—ผ๐˜„: https://www.imarcgroup.com/request?type=report&id=6114&flag=C

๐†๐ฅ๐จ๐›๐š๐ฅ ๐‚๐ž๐ง๐ญ๐ซ๐š๐ฅ ๐๐ž๐ซ๐ฏ๐จ๐ฎ๐ฌ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ (๐‚๐๐’) ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ 2023-2028 ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž:

The competitive landscape of the central nervous system (CNS) therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.

๐—ฆ๐—ผ๐—บ๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ๐˜€๐—ฒ ๐—ธ๐—ฒ๐˜† ๐—ฝ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€ ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ฒ:

AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

๐—ž๐—ฒ๐˜† ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป:

The report has segmented the central nervous system (CNS) therapeutics market bases on disease and application.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

The report has been segmented the market into following categories:

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž:

Neurodegenerative Diseases
Alzheimer's Disease
Parkinson's Disease
Multiple Sclerosis
Huntington's Disease
Amyotrophic Lateral Sclerosis
Others
Neurovascular Diseases
CNS Trauma
Mental Health
Anxiety Disorders
Epilepsy
Mood Disorders
Psychotic Disorders
Others
Infectious Diseases
CNS Cancer
Others

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

Hospital
Clinic
Homecare
Others

๐๐ซ๐ž๐š๐ค๐ฎ๐ฉ ๐›๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

๐—”๐˜€๐—ธ ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐˜ ๐—ณ๐—ผ๐—ฟ ๐Ÿญ๐Ÿฌ% ๐—ณ๐—ฟ๐—ฒ๐—ฒ ๐—ฐ๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฒ๐—ฑ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜: https://www.imarcgroup.com/central-nervous-system-therapeutics-market

๐—ž๐—ฒ๐˜† ๐—›๐—ถ๐—ด๐—ต๐—น๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:

โ€ข Market Performance (2017-2022)
โ€ข Market Outlook (2023-2028)
โ€ข Market Trends
โ€ข Market Drivers and Success Factors
โ€ข Impact of COVID-19
โ€ข Value Chain Analysis
โ€ข Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Ž๐ญ๐ก๐ž๐ซ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ-

Global Talc Market Report- https://www.openpr.com/news/2995621/talc-market-grow-at-cagr-of-4-6-during-2023-2028-imarc-group

Global eVTOL Aircraft Market Report- https://www.openpr.com/news/2962554/evtol-aircraft-market-worth-us-21-62-billion-by-2027-at-cagr

Global Medical Disposables Market Report- https://www.openpr.com/news/2961687/medical-disposables-market-worth-us-680-2-billion-by-2028

๐—–๐—ผ๐—ป๐˜๐—ฎ๐—ฐ๐˜ ๐—จ๐—ฆ:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 |
Europe & Africa: +44-753-713-2163 |
Asia: +91-120-433-0800

๐—”๐—ฏ๐—ผ๐˜‚๐˜ ๐—จ๐˜€:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Central Nervous System (CNS) Therapeutics Market Size To Hit US$ 214.6 Billion by 2028 | IMARC Group here

News-ID: 2995950 • Views: โ€ฆ

More Releases from IMARC Group

Geo-Textile Manufacturing Plant Setup Cost 2025: CapEx/OpEx Analysis with Profitability Forecasts
Geo-Textile Manufacturing Plant Setup Cost 2025: CapEx/OpEx Analysis with Profit โ€ฆ
Setting up a geo-textile manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Geo-Textile Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a geo-textile manufacturing plant, coveringโ€ฆ
Cashew Butter Manufacturing Plant Report 2025: Raw Materials, Investment Opportunities, Cost and Revenue
Cashew Butter Manufacturing Plant Report 2025: Raw Materials, Investment Opportu โ€ฆ
Cashew butter is a creamy spread made by grinding roasted cashew nuts into a smooth paste, often enhanced with a pinch of salt or sweeteners. It is rich in healthy fats, protein, vitamins, and minerals, making it a nutritious alternative to traditional spreads like peanut butter. Cashew butter is widely used as a spread, in smoothies, baked goods, and health-focused recipes, gaining popularity among health-conscious consumers, vegans, and those seekingโ€ฆ
Calcium Chloride Anhydrous Production Cost Report 2025: Plant Setup Economics and Financial Outlook
Calcium Chloride Anhydrous Production Cost Report 2025: Plant Setup Economics an โ€ฆ
Setting up a calcium chloride anhydrous production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Calcium Chloride Anhydrous Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing aโ€ฆ
Paper Bag Manufacturing Plant Cost Report 2025: Layout, Machinery, Raw Materials, and Financial Outlook
Paper Bag Manufacturing Plant Cost Report 2025: Layout, Machinery, Raw Materials โ€ฆ
Setting up a paper bag manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations. IMARC Group's report titled "Paper Bag Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a paper bagโ€ฆ

All 5 Releases


More Releases for CNS

CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0] China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province. According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,โ€ฆ
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T โ€ฆ
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886 This latest reportโ€ฆ
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The โ€ฆ
MARKET INTRODUCTION The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous systemโ€ฆ
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo โ€ฆ
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, andโ€ฆ
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of theโ€ฆ
CNS Therapeutics Market Research Report 2016
โ€œGlobal CNS Therapeutics Market Research Report 2016โ€ Order This Report by calling BigMarketResearch.com at +1-971-202-1575 Notes: Production, means the output of CNS Therapeutics Revenue, means the sales value of CNS Therapeutics This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Pfizer, Inc. (USA) Johnson & Johnson (USA) Bristol-Myers Squibbโ€ฆ